Dr. Reddy’s Laboratories informs about updates

28 Oct 2023 Evaluate

Dr. Reddy’s Laboratories has informed that the United States Food & Drug Administration (USFDA) completed a routine cGMP inspection at its formulations manufacturing facility (FTO-3) in Bachupally, Hyderabad. The inspection was conducted from October 19, 2023 to October 27, 2023. The company has been issued a Form 483 with ten observations, which will address within the stipulated timeline.

The above information is a part of company’s filings submitted to BSE.

Dr. Reddys Lab Share Price

1213.90 19.35 (1.62%)
22-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1797.80
Dr. Reddys Lab 1213.90
Cipla 1486.30
Lupin 2069.95
Zydus Lifesciences 948.70
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.